Salim Yusuf
Overview
Explore the profile of Salim Yusuf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
1092
Citations
67601
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joseph P, Lanas F, Roth G, Lopez-Jaramillo P, Lonn E, Miller V, et al.
Lancet Reg Health Am
. 2025 Mar;
42:100960.
PMID: 40034110
This first article of the Series about Cardiovascular Disease in the Americas summarizes the epidemiology of CVD and its risk factors, and population-level strategies in place aimed at CVD prevention....
2.
Lan L, Lang X, Mckee M, Tse L, Rangarajan S, Qiang D, et al.
BMC Public Health
. 2025 Feb;
25(1):750.
PMID: 39994596
Background: Prolonged sitting time is associated with an increased risk of cardiovascular disease (CVD) in the general population. However, it is unclear how these risks differ across occupational groups. This...
3.
Joseph P, Avezum A, Ramasundarahettige C, Mony P, Yusuf R, Kazmi K, et al.
J Am Coll Cardiol
. 2025 Feb;
85(5):436-447.
PMID: 39909677
Background: It is unclear whether global use of medications for secondary cardiovascular (CVD) prevention is improving over time. Objectives: This study across 17 high-, middle- and low-income countries described variations...
4.
Benz A, Alings M, Bosch J, Avezum A, Bhatt D, Healey J, et al.
Heart Rhythm
. 2025 Jan;
PMID: 39826637
Background: The Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial enrolled patients with vascular disease but excluded patients requiring oral anticoagulation. Objective: We aimed to explore the clinical significance...
5.
Ke C, Anand S, Smith E, Schulze K, Moody A, Lear S, et al.
Neurology
. 2025 Jan;
104(3):e210246.
PMID: 39787476
Background And Objective: It is unclear whether variation in covert cerebrovascular disease prevalence is attributable to ethnic differences or to other factors. We aimed to examine the associations of country...
6.
Leong D, Joseph P, Dokainish H, Stork S, McMurray J, Mielniczuk L, et al.
Eur J Heart Fail
. 2024 Dec;
PMID: 39675787
Aims: The aim of this study was to describe the prognostic importance of left ventricular ejection fraction (LVEF) versus right ventricular (RV) dilatation and dysfunction in patients with heart failure...
7.
Jolly S, dEntremont M, Lee S, Mian R, Tyrwhitt J, Kedev S, et al.
N Engl J Med
. 2024 Nov;
392(7):633-642.
PMID: 39555823
Background: Inflammation is associated with adverse cardiovascular events. Data from recent trials suggest that colchicine reduces the risk of cardiovascular events. Methods: In this multicenter trial with a 2-by-2 factorial...
8.
Jolly S, dEntremont M, Pitt B, Lee S, Mian R, Tyrwhitt J, et al.
N Engl J Med
. 2024 Nov;
392(7):643-652.
PMID: 39555814
Background: Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is beneficial after myocardial infarction is...
9.
Reddin C, Canavan M, Hankey G, Oveisgharan S, Langhorne P, Wang X, et al.
Neurology
. 2024 Nov;
103(11):e210087.
PMID: 39536279
Background And Objectives: Acute stroke is associated with a spectrum of functional deficits. The objective of this analysis was to explore whether the importance of individual risk factors differ by...
10.
Bangdiwala S, Yusuf S
Clin Trials
. 2024 Nov;
:17407745241290729.
PMID: 39520228
Monitoring the conduct of phase III randomized controlled trials is driven by ethical reasons to protect the study integrity and the safety of trial participants. We propose a group sequential,...